Causes of Colectomy in Patients with Ulcerative Colitis: Findings from an Iranian National Registry.


Journal

Archives of Iranian medicine
ISSN: 1735-3947
Titre abrégé: Arch Iran Med
Pays: Iran
ID NLM: 100889644

Informations de publication

Date de publication:
01 Jul 2024
Historique:
received: 02 02 2024
accepted: 05 06 2024
medline: 29 7 2024
pubmed: 29 7 2024
entrez: 29 7 2024
Statut: epublish

Résumé

Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) marked by rectal and colon inflammation, leading to relapsing symptoms. Its prevalence is increasing, particularly in developed nations, impacting patients' health. While its exact cause remains unclear, genetic and environmental factors are implicated, elevating the risk of colorectal cancer (CRC). Colectomy, though declining, is still performed in select UC cases, necessitating further study. We analyzed data from the Iranian Registry of Crohn's and Colitis (IRCC) to examine UC patients undergoing colectomy. We collected demographic and clinical data from 91 patients, focusing on dysplasia. Statistical analyses assessed dysplasia risk factors. Patients with dysplasia were older at diagnosis and surgery compared to those without dysplasia. Age emerged as a significant risk factor for dysplasia in UC patients undergoing colectomy. No significant associations were found between dysplasia and other factors. Age plays a crucial role in dysplasia risk among UC patients undergoing colectomy. Older age at diagnosis and surgery may indicate a higher risk of dysplasia and CRC. Clinicians should consider age when managing UC patients and implementing screening protocols. Further research with larger samples is needed to confirm these findings.

Sections du résumé

BACKGROUND BACKGROUND
Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) marked by rectal and colon inflammation, leading to relapsing symptoms. Its prevalence is increasing, particularly in developed nations, impacting patients' health. While its exact cause remains unclear, genetic and environmental factors are implicated, elevating the risk of colorectal cancer (CRC). Colectomy, though declining, is still performed in select UC cases, necessitating further study.
METHODS METHODS
We analyzed data from the Iranian Registry of Crohn's and Colitis (IRCC) to examine UC patients undergoing colectomy. We collected demographic and clinical data from 91 patients, focusing on dysplasia. Statistical analyses assessed dysplasia risk factors.
RESULTS RESULTS
Patients with dysplasia were older at diagnosis and surgery compared to those without dysplasia. Age emerged as a significant risk factor for dysplasia in UC patients undergoing colectomy. No significant associations were found between dysplasia and other factors.
CONCLUSION CONCLUSIONS
Age plays a crucial role in dysplasia risk among UC patients undergoing colectomy. Older age at diagnosis and surgery may indicate a higher risk of dysplasia and CRC. Clinicians should consider age when managing UC patients and implementing screening protocols. Further research with larger samples is needed to confirm these findings.

Identifiants

pubmed: 39072382
doi: 10.34172/aim.28887
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-356

Informations de copyright

© 2024 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Auteurs

Zahra Momayez Sanat (Z)

Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Homayoon Vahedi (H)

Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Reza Malekzadeh (R)

Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Amir Kasaeian (A)

Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Research Center for Chronic Inflammatory Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Clinical Research Development Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Negar Mohammadi Ganjaroudi (N)

School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Alireza Sima (A)

Sasan Alborz Biomedical Research Center, Masoud Gastroenterology and Hepatology Center, Tehran, Iran.

Fariborz Mansour Ghanaei (F)

Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Guilan, Iran.

Mohammadreza Ghadir (M)

Gastroenterology and Hepatology Diseases Research Center, Qom University of Medical Science, Qom, Iran.

Hafez Tirgar Fakheri (H)

Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Siavosh Nasseri Moghaddam (S)

Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Sudabeh Alatab (S)

Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Anahita Sadeghi (A)

Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Amir Anushiravani (A)

Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Iradj Maleki (I)

Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Abbas Yazdanbod (A)

Digestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.

Hassan Vossoughinia (H)

Department of Gastroenterology and Hepatology, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammadreza Seyyedmajidi (M)

Golestan Research Center of Gastroenterology, Golestan University of Medical Science, Gorgan, Iran.

Sayed Jalaleddin Naghshbandi (SJ)

Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Nadieh Baniasadi (N)

Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.

Baran Parhizkar (B)

Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Saied Matinkhah (S)

Isfahan University of Medical Sciences, Isfahan, Iran.

Shahsanam Gheibi (S)

Maternal and Childhood Obesity Research center, Urmia University of Medical Sciences, Urmia, Iran.

Roya-Sadat Hosseini Hemmat Abadi (RS)

Shahid Sadoughi University, Yazd, Iran.

Seyedmohamad Valizadeh Toosi (S)

Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH